Racial And Ethnic Disparities In Buprenorphine Receipt Among Medicare Beneficiaries, 2015-19.
Autor: | Miles J; Jennifer Miles (jm2462@ssw.rutgers.edu), Rutgers University, New Brunswick, New Jersey., Treitler P; Peter Treitler, Rutgers University., Lloyd J; James Lloyd, Rutgers University., Samples H; Hillary Samples, Rutgers University., Mahone A; Anais Mahone, Rutgers University., Hermida R; Richard Hermida, Rutgers University., Gupta S; Sumedha Gupta, Indiana University-Purdue University Indianapolis, Indianapolis, Indiana., Duncan A; Alexandra Duncan, Pew Charitable Trusts, Washington, D.C., Baaklini V; Vanessa Baaklini, Pew Charitable Trusts., Simon KI; Kosali I. Simon, Indiana University, Bloomington, Indiana., Crystal S; Stephen Crystal, Rutgers University. |
---|---|
Jazyk: | angličtina |
Zdroj: | Health affairs (Project Hope) [Health Aff (Millwood)] 2023 Oct; Vol. 42 (10), pp. 1431-1438. |
DOI: | 10.1377/hlthaff.2023.00205 |
Abstrakt: | We examined Medicare Part D claims from the period 2015-19 to identify state and national racial and ethnic disparities in buprenorphine receipt among Medicare disability beneficiaries with diagnosed opioid use disorder or opioid overdose. Racial and ethnic disparities in buprenorphine use remained persistently high during the study period, especially for Black beneficiaries, suggesting the need for targeted interventions and policies. |
Databáze: | MEDLINE |
Externí odkaz: |